• Je něco špatně v tomto záznamu ?

Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients

AP. Marušič, I. Locatelli, A. Mrhar, M. Caprnda, L. Gaspar, M. Adamek, P. Kruzliak, D. Petrovič,

. 2017 ; 23 (8) : 938-942. [pub] 20170125

Jazyk angličtina Země Spojené státy americké

Typ dokumentu klinické zkoušky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010839

Deep vein thrombosis (DVT) and pulmonary embolisms (PEs) are common complications after surgical procedures. The influence of prescribed blood products on the occurrence of DVT and PE was evaluated in postsurgical patients in this retrospective case-control study. The records of 286 surgical patients were analyzed: DVT (n = 52), PE (n = 92), and a control group (n = 142). The amounts of prescribed blood, blood products, and vitamin K were reviewed, together with appropriate prescribing of low-molecular-weight heparins. The influence of prescribed blood products on the occurrence of DVT or PE was analyzed using multinomial logistic regression. We demonstrated a significant difference between the test and control groups ( P < .05) in relation to receiving packed red blood cells. Treatment with red blood cells was associated with an increased risk of PE but not DVT. Patients who developed PE after surgery were hospitalized for longer (median 10 days) than patients with DVT (median 6 days). There was no difference between the test and control groups concerning treatment with fresh frozen plasma. Inadequate thromboprophylaxis significantly increased the likelihood of DVT. There is a connection between receiving packed red blood cells and occurrence of postoperative PE in surgical patients. Thus, patients receiving red blood cells should be monitored more closely after surgery, as they are more likely to develop PE postoperatively.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010839
003      
CZ-PrNML
005      
20180426101918.0
007      
ta
008      
180404s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/1076029616689301 $2 doi
035    __
$a (PubMed)28118751
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Marušič, Alenka Premuš $u 1 Hospital Pharmacy, General Hospital Murska Sobota, Murska Sobota, Slovenia. 2 Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
245    10
$a Influence of Prescribed Blood Products on the Incidence of Deep Vein Thrombosis and Pulmonary Embolism in Surgical Patients / $c AP. Marušič, I. Locatelli, A. Mrhar, M. Caprnda, L. Gaspar, M. Adamek, P. Kruzliak, D. Petrovič,
520    9_
$a Deep vein thrombosis (DVT) and pulmonary embolisms (PEs) are common complications after surgical procedures. The influence of prescribed blood products on the occurrence of DVT and PE was evaluated in postsurgical patients in this retrospective case-control study. The records of 286 surgical patients were analyzed: DVT (n = 52), PE (n = 92), and a control group (n = 142). The amounts of prescribed blood, blood products, and vitamin K were reviewed, together with appropriate prescribing of low-molecular-weight heparins. The influence of prescribed blood products on the occurrence of DVT or PE was analyzed using multinomial logistic regression. We demonstrated a significant difference between the test and control groups ( P < .05) in relation to receiving packed red blood cells. Treatment with red blood cells was associated with an increased risk of PE but not DVT. Patients who developed PE after surgery were hospitalized for longer (median 10 days) than patients with DVT (median 6 days). There was no difference between the test and control groups concerning treatment with fresh frozen plasma. Inadequate thromboprophylaxis significantly increased the likelihood of DVT. There is a connection between receiving packed red blood cells and occurrence of postoperative PE in surgical patients. Thus, patients receiving red blood cells should be monitored more closely after surgery, as they are more likely to develop PE postoperatively.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a transfuze erytrocytů $7 D017707
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a heparin nízkomolekulární $x aplikace a dávkování $7 D006495
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a krevní plazma $7 D010949
650    _2
$a pooperační komplikace $x epidemiologie $x terapie $7 D011183
650    _2
$a plicní embolie $x epidemiologie $x etiologie $x terapie $7 D011655
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a žilní trombóza $x epidemiologie $x etiologie $x terapie $7 D020246
650    _2
$a vitamin K $x aplikace a dávkování $7 D014812
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
700    1_
$a Locatelli, Igor $u 2 Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
700    1_
$a Mrhar, Aleš $u 2 Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
700    1_
$a Caprnda, Martin $u 3 2nd Department of Internal Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
700    1_
$a Gaspar, Ludovit $u 3 2nd Department of Internal Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
700    1_
$a Adamek, Mariusz $u 4 Department of Thoracic Surgery, Medical University of Silesia, Katowice, Poland.
700    1_
$a Kruzliak, Peter $u 5 Department of Chemical Drugs, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic. 6 2nd Department of Surgery, Masaryk University, Brno, Czech Republic.
700    1_
$a Petrovič, Daniel $u 7 Faculty of Medicine, Institute of Histology and Embryology, University of Ljubljana, Ljubljana, Slovenia.
773    0_
$w MED00001108 $t Clinical and applied thrombosis/hemostasis $x 1938-2723 $g Roč. 23, č. 8 (2017), s. 938-942
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28118751 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180426102029 $b ABA008
999    __
$a ok $b bmc $g 1288324 $s 1007651
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 23 $c 8 $d 938-942 $e 20170125 $i 1938-2723 $m Clinical and applied thrombosis/hemostasis $n Clin Appl Thromb Hemost $x MED00001108
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Možnosti archivace